omega-n-methylarginine has been researched along with sphingosine phosphorylcholine in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (sphingosine phosphorylcholine) | Trials (sphingosine phosphorylcholine) | Recent Studies (post-2010) (sphingosine phosphorylcholine) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 263 | 2 | 61 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, S; Matsuda, M; Matsuzaki, M; Miwa, S; Mizukami, Y; Mogami, K; Ohmura, M; Todoroki-Ikeda, N; Yoshida, K | 1 |
1 other study(ies) available for omega-n-methylarginine and sphingosine phosphorylcholine
Article | Year |
---|---|
Sphingosylphosphorylcholine induces cytosolic Ca(2+) elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery.
Topics: Animals; Calcium; Calcium Signaling; Cattle; Coronary Vessels; Cytosol; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Phosphorylcholine; Polymethacrylic Acids; Sphingosine; Vasodilation | 1999 |